ERBB2 and breast carcinoma: To assess the associations between cellular heterogeneity for ERBB2 copy number and mutant PIK3CAH1047R as well as response to treatment and changes in heterogeneity due to therapy, we performed STAR-FISH on cases from 2 uniformly treated cohorts of patients with HER2+ breast cancer.